Bora Pharmaceutical: Announcement on Subsidiary Endorsement Guarantee Balance Reaching Article 25, Paragraph 1, Subparagraph 4 of the 'Regulations Governing the Lending of Funds and Making of Endorsements/Guarantees by Public Companies'
Bora Pharmaceutical announced that its endorsement guarantee balance to its subsidiary, Bora Global Ltd., has reached the threshold specified in Article 25, Paragraph 1, Subparagraph 4 of the 'Regulations Governing the Lending of Funds and Making of Endorsements/Guarantees by Public Companies'. This constitutes a significant disclosure in the company's financial reporting.
📋 Article Processing Timeline
- 📰 Published: May 13, 2026 at 09:00
- 🔍 Collected: May 14, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 14, 2026 at 08:25 (24 min after Collected)
1. Date of occurrence of the event: 2026/05/13
2. Counterparty of the endorsement/guarantee:
(1) Company name: Bora Global Ltd.
(2) Relationship with the company providing the endorsement/guarantee: A 100% directly held subsidiary of the company
(3) Limit of endorsement/guarantee (in thousands of NTD): 72,844,305
(4) Original balance of endorsement/guarantee (in thousands of NTD): 630,300
(5) Amount of newly added endorsement/guarantee (in thousands of NTD): 945,450
(6) Balance of endorsement/guarantee as of the date of occurrence (in thousands of NTD): 1,575,750
(7) Actual amount used by the counterparty of the endorsement/guarantee (in thousands of NTD): 0
(8) Reason for newly added endorsement/guarantee: The company provides a credit line guarantee for its subsidiary
3. Collateral provided by the counterparty of the endorsement/guarantee:
(1) Content: None
(2) Value (in thousands of NTD): 0
4. Most recent financial statement of the counterparty of the endorsement/guarantee:
(1) Capital (in thousands of NTD): 12,606
(2) Accumulated profit/loss (in thousands of NTD): 359
5. Conditions for releasing the endorsement/guarantee liability:
(1) Conditions: As per contract terms
(2) Date: As per contract terms
6. Total limit of endorsement/guarantee (in thousands of NTD): 72,844,305
7. Balance of endorsement/guarantee as of the date of occurrence (in thousands of NTD): 11,393,548
8. Ratio of endorsement/guarantee balance to the net worth of the publicly issued company's most recent financial statement as of the date of occurrence: 78.20%
9. Total of endorsement/guarantee, long-term investments, and loans to others as a ratio to the net worth of the publicly issued company's most recent financial statement as of the date of occurrence: 10.91%
10. Other matters that need to be specified: None
2. Counterparty of the endorsement/guarantee:
(1) Company name: Bora Global Ltd.
(2) Relationship with the company providing the endorsement/guarantee: A 100% directly held subsidiary of the company
(3) Limit of endorsement/guarantee (in thousands of NTD): 72,844,305
(4) Original balance of endorsement/guarantee (in thousands of NTD): 630,300
(5) Amount of newly added endorsement/guarantee (in thousands of NTD): 945,450
(6) Balance of endorsement/guarantee as of the date of occurrence (in thousands of NTD): 1,575,750
(7) Actual amount used by the counterparty of the endorsement/guarantee (in thousands of NTD): 0
(8) Reason for newly added endorsement/guarantee: The company provides a credit line guarantee for its subsidiary
3. Collateral provided by the counterparty of the endorsement/guarantee:
(1) Content: None
(2) Value (in thousands of NTD): 0
4. Most recent financial statement of the counterparty of the endorsement/guarantee:
(1) Capital (in thousands of NTD): 12,606
(2) Accumulated profit/loss (in thousands of NTD): 359
5. Conditions for releasing the endorsement/guarantee liability:
(1) Conditions: As per contract terms
(2) Date: As per contract terms
6. Total limit of endorsement/guarantee (in thousands of NTD): 72,844,305
7. Balance of endorsement/guarantee as of the date of occurrence (in thousands of NTD): 11,393,548
8. Ratio of endorsement/guarantee balance to the net worth of the publicly issued company's most recent financial statement as of the date of occurrence: 78.20%
9. Total of endorsement/guarantee, long-term investments, and loans to others as a ratio to the net worth of the publicly issued company's most recent financial statement as of the date of occurrence: 10.91%
10. Other matters that need to be specified: None